CHICAGO — Results showed a high-dose injection of allogeneic disc progenitor cells for treatment of degenerative disc disease yielded statistically significant improvements in low back pain, function, quality of life and disc volume.
“Early data shows not only can we decrease patients’ back pain, improve their function as measured by the Oswestry Disability Index, [and] decrease their narcotic usage, but, most important of all, we’re seeing that we can regrow their disc and, intuitively, something that can regrow their disc and improve disc height and volume is a game
